-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Gilead Sciences, Raises Price Target to $190

Benzinga·10/30/2026 22:40:58
Listen to the news
JP Morgan analyst Chris Schott maintains Gilead Sciences (NASDAQ:GILD) with a Overweight and raises the price target from $170 to $190.